Pazopanib - analogs
Components: Pazopanib |
|||||||||
Pharmgroups: Antitumor agents - protein kinase inhibitors |
|||||||||
Prices in pharmacies: — Instructions Pazopanib | |||||||||
|
ⓘ✘Enter drugs for проверки взаимодействовий through a quick button search . Levodopa+Carbidopa ✘ (incl) Капсулы «Вэйкан» Тяньши ✘ (incl) УМКА МУЛЬТИВИТ ФОРТЕ Мармеладные пастилки с витаминами ✘ (incl) Меделла-1 ✘ (incl) Эстровэл NDM ✘ (incl) Multimax Superstress New ✘ (incl) Соновит. Серия «Букет Здоровья» ✘ (incl) Фитокомплекс ЛАКС капсулы ✘ (incl) Ренессанс. Антиокс Экстра ✘ (incl) Чаванпраш ✘ (incl) GNC Milk Thistle ✘ (incl) Фиточай №25 серии «Дары природы» ✘ (incl) GNC Cascara Sagrada ✘ (incl) Glucobalance ✘ (incl) Юнивит Кальций Д3 для малышей ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. |
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Similar | Complete analog ⓘ✘Аналоги препарата с полностью совпадающими действующими веществами |
Prices in pharmacies |
≈100% | Votrient neutral | 882-1043.3€ |
≈100% | Pazopanib-TL neutral | — |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 58% — Sunitinib neutral [Sunitinib]
- 56% 153.1-1937.3€ Sutent neutral [Sunitinib]
- 43% — Imatinib neutral [Imatinib]
- 43% — Албитиниб neutral [Imatinib]
- 43% — Иматиниб-Сигардис neutral [Imatinib]
- 42% 830-1485.8€ Nexavar neutral [Sorafenib]
- 42% — Сорафениба тозилат neutral [Sorafenib]
- 42% — Сорафениб-натив neutral [Sorafenib]
- 42% — Сорафениб геми-тозилат моногидрат neutral [Sorafenib]
- 42% — Сорафениб-АМЕДАРТ neutral [Sorafenib]
- 42% — Сорафениб-промомед neutral [Sorafenib]
- 42% — Флутриксан neutral [Sorafenib]
- 41% 1732.5€ Lenvima neutral [Lenvatinib]
- 40% 42.3-61€ Philachromin FS neutral [Imatinib]
- 40% 114.4-127.7€ Glivec neutral [Imatinib]
- 40% 1685.1€ Yondelis neutral [Trabectedin]
- 39% 3936.6€ Кабометикс neutral [Cabozantinib]
- 37% — Sorafenib neutral [Sorafenib]
- 36% 2016.2€ Sunitinib-nativ neutral [Sunitinib]
- 33% — Сунитиниба малат neutral [Sunitinib]
- 32% — Tamoxifen-Ebewe neutral [Tamoxifen]
- 29% 13.3-426€ Bevacizumab neutral [Bevacizumab]
- 29% — Версаво neutral [Bevacizumab]
- 29% 80-300€ Авегра БИОКАД neutral [Bevacizumab]
- 28% 363.3-1164.9€ Afinitor neutral [Everolimus and more 1Butylated hydroxytoluene]
- 26% — Imatinib Dr. Reddy s neutral [Imatinib]
- 26% 4850€ Imbruvica neutral [Ibrutinib]
- 26% 605€ Imatib neutral [Imatinib]
- 26% — Глемихиб neutral [Imatinib]
- 26% — Цитонибонко neutral [Imatinib]
- 26% — Imatinib-Teva neutral [Imatinib]
- 26% 271€ Neopax neutral [Imatinib]
- 26% — Imatinib Grindex neutral [Imatinib]
- 26% — Imatinib-TL neutral [Imatinib]
- 26% — Imvec neutral [Imatinib]
- 25% 590-1010€ Zelboraf neutral [Vemurafenib and more 1Hypromellose]
- 25% 291.9-1935.3€ Inlyta neutral [Axitinib]
- 25% 296€ Halaven neutral [Eribulin]
- 24% 862.9€ Vargatef neutral [Nintedanib]
- 24% 89.9-339.6€ Avastin neutral [Bevacizumab]
- 24% — Gallium citrate, 67Ga neutral [Gallium [67Ga] citrate]
- 23% 228€ Dactinomycin neutral [Dactinomycin]
- 22% 118€ Cosmegen neutral [Dactinomycin]
- 22% 48.7€ Philachromin neutral [Imatinib]
- 22% — Erlotinib neutral [Erlotinib]
- 22% — Genfatinib neutral [Imatinib]
- 21% — Дазатиниб neutral [Dasatinib]
- 21% 1.3-2.1€ Milurit neutral [Allopurinol]
- 21% 21.3-27.4€ Азурикс neutral [Febuxostat]
- 21% — Фебуксостат neutral [Febuxostat]
Learn more about the selection of analogues
- The drug has «Pazopanib» 5 full analogs, the cheapest - Votrient (882-1043.3€); 51 analog by action, the most similar - Sutent (153.1-1937.3€).
- Medical online service has selected the best substitutes for Pazopanib based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of Pazopanib analogues to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.